NASDAQ:CLSD   Clearside Biomedical, Inc.
Uptrend Consolidation
SMA200 as support
OBV> OBV34
WR% Crossed -80

Entry 2.47
Stop 2
Target 4.3

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
交易开始:
BuyToOpen (BTO) 2022 Jan C2.5/5 limit 0.45
Delta 0.4
No Stop in this OP trade;
MAX RRR 4:1
交易结束:到达目标:
closed 1.15, small winner
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。